Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Genmab A/S - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
GMAB
Nasdaq
2830
www.genmab.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Genmab A/S
Genmab (GMAB) Q3 2026 Earnings Call Transcript
- Nov 6th, 2026 9:16 am
Moody’s lifts Genmab outlook to positive on pipeline progress, debt reduction
- Nov 6th, 2026 9:02 am
Genmab AS (GMAB) (Q3 2026) Earnings Call Highlights: Revenue Jumps 22% as Epkinly and Pipeline ...
- Nov 6th, 2026 12:15 am
What Genmab A/S (GMAB) Said on Its Q3 Earnings Call
- Nov 5th, 2026 1:14 pm
Genmab shares fall 3% after Q3 revenue slightly misses expectations
- Nov 5th, 2026 11:07 am
Genmab Announces Financial Results for the Nine Months of 2026
- Nov 5th, 2026 9:02 am
Genmab to Present Results from Comprehensive Epcoritamab Development Program Highlighting Potential Across B-Cell Malignancies at the 2026 American Society of Hematology (ASH) Annual Meeting
- Nov 4th, 2026 7:00 am
Genmab to Present Results from Comprehensive Epcoritamab Development Program Highlighting Potential Across B-Cell Malignancies at the 2026 American Society of Hematology (ASH) Annual Meeting
- Nov 4th, 2026 7:00 am
Genmab Stock Price Shock Puts 3 Oncology Biotech Names In Focus
- Nov 3rd, 2026 5:10 am
Can Genmab (CPSE:GMAB) Still Be Undervalued After Its Trial Wins?
- Oct 29th, 2026 5:17 pm
Genmab’s bispecific halves risk of death in first-line HNSCC
- Oct 29th, 2026 10:24 am
Genmab soars to record highs after cancer drug succeeds in key trial
- Oct 29th, 2026 10:06 am
Why Did ETSY, REPL, GMAB Stocks Surge To 52-Week Highs Today?
- Oct 28th, 2026 9:07 pm
Genmab’s Three Positive Phase III Readouts Set Stage for Potential 2027 Cancer Launches
- Oct 28th, 2026 3:04 pm
Genmab Stock Surges to Record High After Stunning Cancer Drug Results
- Oct 28th, 2026 2:19 pm
Genmab Stock Hits 52-Week High - Here's Why
- Oct 28th, 2026 11:44 am
Top Midday Gainers
- Oct 28th, 2026 11:36 am
GMAB Stock Hits All-Time High After Genmab’s Cancer Drug Trial Meets Primary Goals — Here’s What Investors Need To Know
- Oct 28th, 2026 11:24 am
Genmab stock surges 16% on positive cancer trial results
- Oct 28th, 2026 8:24 am
Scroll